Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:45:29 EDT Mon 22 Jun 2026
Enter Symbol
or Name
USA
CA



Q:CPRX - CATALYST PHARMACEUTICALS INC - https://www.copper-ridge.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CPRX - Q9.231.38·31.3929.531.385+0.0050.0796.224,5675,96831.38  31.40  31.3832.56  19.0514:27:59May 1115 min RT 2¢

Recent Trades - Last 10 of 5968
Time ETExPriceChangeVolume
14:28:08Q31.3850.00513
14:27:59Q31.38270.00276
14:27:59Q31.38520.00524
14:27:56Q31.38270.00277
14:27:55Q31.3850.00512
14:27:55Q31.3850.0052
14:27:51Q31.3840.0048
14:27:50Q31.3850.0052
14:27:50Q31.3850.0051
14:27:50Q31.3850.00529

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-11 16:13U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
2026-05-07 16:02U:CPRXNews ReleaseCatalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast
2026-05-07 03:26U:CPRXNews ReleaseAngelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
2026-05-07 02:44U:CPRXNews ReleaseCatalyst Pharmaceuticals Announces Settlement of FIRDAPSE(TM) (amifampridine) Patent Litigation with Hetero Labs Ltd.
2026-04-28 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
2026-03-06 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Showcase Real-World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
2026-02-25 16:08U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
2026-02-24 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
2026-02-11 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
2026-01-08 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
2026-01-05 08:03U:CPRXNews ReleaseThe University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
2025-12-15 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2025-11-24 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
2025-11-19 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500(TM)
2025-11-18 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference
2025-11-05 16:07U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
2025-11-04 16:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
2025-11-03 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
2025-10-22 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025